Dr. Philipp Scherer, a professor and the director of the Touchstone Center for Diabetes Research at UT Southwestern Medical Center, is among three other doctors who have received recognition for their work in medicine.
The award was given by The Academy of Medicine, Engineering and Science of Texas (TAMEST). A $25,000 honorarium, a citation and a trophy was given as part of the award.
Those who receive the award will also be given the opportunity to speak at a conference.
Dr. Scherer was given the award for his work on fat derived hormones and how they control sensitivity to insulin. Dr. Scherer also discovered the protein adiponectin during research carried out in 1994. A decline of this hormone can be an indicator of diabetes, heart disease and cancer risk, according to the press release.
The committee also cited the work carried out by Dr. Scherer into fat cells called adipocytes.
In a press release, Dr. Scherer explains:
“Fat tissue remains one of the most enigmatic tissues we have. It fulfills an essential role in storing excess calories, yet too much of it increases our risk to develop diabetes, cardiovascular disease and cancer."
“We hope that our efforts highlight new avenues of how we can maintain proper function of fat cells, while still allowing them to effectively absorb the excess of toxic lipids that we expose ourselves to in our daily diet.”
Dr. Daniel K. Podolsky, president of UT Southwestern, said
“Dr. Scherer’s research contributes to our understanding of the molecular mechanisms of how fat cells communicate with organs and may lead to new ways of fighting diabetes and other obesity-related diseases.”
The award was given by The Academy of Medicine, Engineering and Science of Texas (TAMEST). A $25,000 honorarium, a citation and a trophy was given as part of the award.
Those who receive the award will also be given the opportunity to speak at a conference.
Dr. Scherer was given the award for his work on fat derived hormones and how they control sensitivity to insulin. Dr. Scherer also discovered the protein adiponectin during research carried out in 1994. A decline of this hormone can be an indicator of diabetes, heart disease and cancer risk, according to the press release.
The committee also cited the work carried out by Dr. Scherer into fat cells called adipocytes.
In a press release, Dr. Scherer explains:
“Fat tissue remains one of the most enigmatic tissues we have. It fulfills an essential role in storing excess calories, yet too much of it increases our risk to develop diabetes, cardiovascular disease and cancer."
“We hope that our efforts highlight new avenues of how we can maintain proper function of fat cells, while still allowing them to effectively absorb the excess of toxic lipids that we expose ourselves to in our daily diet.”
Dr. Daniel K. Podolsky, president of UT Southwestern, said
“Dr. Scherer’s research contributes to our understanding of the molecular mechanisms of how fat cells communicate with organs and may lead to new ways of fighting diabetes and other obesity-related diseases.”
No comments:
Post a Comment